Characterization of DNA-binding activity of Zα domains from poxviruses and the importance of the β-wing regions in converting B-DNA to Z-DNA

• Main Authors: Quyen, Dong Van (Author), Ha, Sung Chul (Author), Kim, Kyeong Kyu (Author), Kim, Yang-Gyun (Author), Lowenhaupt, Ky (Contributor), Rich, Alexander (Contributor)
• Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor)
• Format: Article
• Language: English
• Published: Oxford University Press (OUP), 2012-06-01T19:57:28Z.
• Subjects: Article
• Online Access: Get fulltext

The E3L gene is essential for pathogenesis in vaccinia virus. The E3L gene product consists of an N-terminal Zα domain and a C-terminal double-stranded RNA (dsRNA) binding domain; the left-handed Z-DNA-binding activity of the Zα domain of E3L is required for viral pathogenicity in mice. E3L is highly conserved among poxviruses, including the smallpox virus, and it is likely that the orthologous Zα domains play similar roles. To better understand the biological function of E3L proteins, we have investigated the Z-DNA-binding behavior of five representative Zα domains from poxviruses. Using surface plasmon resonance (SPR), we have demonstrated that these viral Zα domains bind Z-DNA tightly. Ability of Zα[subscript E3L] converting B-DNA to Z-DNA was measured by circular dichroism (CD). The extents to which these Zαs can stabilize Z-DNA vary considerably. Mutational studies demonstrate that residues in the loop of the β-wing play an important role in this stabilization. Notably the Zα domain of vaccinia E3L acquires ability to convert B-DNA to Z-DNA by mutating amino acid residues in this region. Differences in the host cells of the various poxviruses may require different abilities to stabilize Z-DNA; this may be reflected in the observed differences in behavior in these Zα proteins.
Korean Science and Engineering Foundation (National Research Laboratory Program (NRL-2006-02287))
Korean Science and Engineering Foundation (Ubiquitome Research Program (M10533010002-06N3301-00210))
Korean Science and Engineering Foundation (21C Frontier Functional Proteomics Program (FPR06B2-120))
National Institutes of Health (U.S.)
Ellison Medical Foundation
Korea (South). Ministry of Science and Technology (National Laboratory program (NRL-2006-02287))